Prenetics Global Limited (PRE)
Nasdaq: PRE · Laboratory Analytical Instruments · Quarry Bay, HK · filing with the SEC since 2021
Who owns Prenetics Global Limited
As filed with the SECHolders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
9
report now, of 9 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
Eastspring Investments (Singapore) Limited
SCHEDULE 13G/A · filed Nov 7, 2024 · Class A ordinary shares · reported falling below 5%
Genetel Bioventures Ltd
SCHEDULE 13G/A · filed Apr 22, 2026 · Class A Ordinary Shares, par value $0.0015 per share · reported falling below 5%
What PRE reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Act Genomics Co.Ltd.
An entity · subsidiary · owns, named in the 20-F filed Apr 30, 2026
Act Genomics Hong Kong Limited
An entity · subsidiary · owns, named in the 20-F filed Apr 30, 2026
Europa Partners Holdings, LLC
An entity · subsidiary · owns, named in the 20-F filed Apr 30, 2026
IM8 Group Holding Compay
An entity · subsidiary · owns, named in the 20-F filed Apr 30, 2026
IM8 Limited
An entity · subsidiary · owns, named in the 20-F filed Apr 30, 2026
MC Diagnostics Limited
An entity · subsidiary · owns, named in the 20-F filed Apr 30, 2026
Prenetics Limited
An entity · subsidiary · owns, named in the 20-F filed Apr 30, 2026
Sanomics Limited
An entity · subsidiary · owns, named in the 20-F filed Apr 30, 2026
21 subsidiaries in 9 countries, from the list filed with the 20-F filed Apr 30, 2026.
Insider tradesForm 4
0sales
5purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$1.0Mbought, in dollars
Open-market trades on Form 4 from Nov 5, 2025 to Nov 5, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 5, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 11 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Yeung Danny Sheng Wu | Chief Executive Officer | 0 | $0 | 0 | 3 | $500,000 |
| Rosin Brian J | CFO of IM8 (US) LLC | 0 | $0 | 0 | 2 | $500,000 |